Connecticut Children’s Medical Center has been named to the Most Wired list of hospitals for the second consecutive year. Hospital winners are those who make it easier for patients and providers to interact, thus improving communication, safety and patient-provider relationships.
As we honor National Lead Poisoning Prevention Week, Connecticut Children’s Healthy Homes Program (Healthy Homes) is excited to announce it is expanding statewide after receiving a generous state grant.
Connecticut Children’s Medical Center has been named as a Best Children’s Hospital by the Women’s Choice Award®, America’s trusted referral source for the best in healthcare.
The Joy in Childhood Foundation, the charitable foundation supported by Dunkin’ Donuts and Baskin-Robbins, today announced that it will create a Starlight Site in Connecticut Children’s Medical Center in Hartford through their $1.5 million partnership with Starlight Children’s Foundation.
Teenagers and young adults fighting cancer and other illness at Connecticut Children’s Medical Center now have access to a brand new arts and crafts cart that will play an important role during their lengthy hospital stays.
Connecticut Children’s Medical Center has acquired HeadZone, based in Shelton, CT the organization announced today. The HeadZone practice specializes in the care of pediatric patients ages 5-22 years, who have sustained head injuries. HeadZone serves hundreds of children each year and shares the same values that serve as the foundation of care at Connecticut Children’s.
Connecticut Children’s neonatology program has outranked its local competitors in the 2018-2019 U.S. News & World Report’s Best Children’s Hospital rankings released today. Connecticut Children’s neonatology program was ranked in the Top 30 nationally by U.S. News & World Report, among more than 1,500 NICUs across the country.
CONNECTICUT CHILDREN’S INJURY PREVENTION CENTER ANNOUNCES RECIPIENTS OF 2018 HAYLEY PETIT INJURY AND VIOLENCE PREVENTION FELLOWSHIPS
CCMC School has transferred ownership to the Family Treatment Network.
This week, the U.S. Food and Drug Administration approved the world’s first gene therapy clinical trial for Glycogen Storage Disease (GSD). This ground breaking clinical trial focusing on GSD Type Ia will be hosted by the GSD Program at Connecticut Children’s Medical Center and UConn Health under the direction of leading pediatric endocrinologist and scientist David Weinstein, MD, MMSc.